UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of the c‑Jun N‑Terminal Kinase Inhibitor CC-90001

Journal of medicinal chemistry, 2021-12, Vol.64 (24), p.18193-18208

2021

Volltextzugriff (PDF)

Systematic Study of Heteroarene Stacking Using a Congeneric Set of Molecular Glues for Procaspase‑6

Journal of medicinal chemistry, 2023-07, Vol.66 (14), p.9784-9796

2023

Volltextzugriff (PDF)

The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen

Journal of medicinal chemistry, 2017-11, Vol.60 (21), p.8989-9002

2017

Volltextzugriff (PDF)

CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization

Molecular cancer therapeutics, 2015-06, Vol.14 (6), p.1295-1305

2015

Volltextzugriff (PDF)

Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB

PLoS pathogens, 2020-06, Vol.16 (6), p.e1008567-e1008567

2020

Volltextzugriff (PDF)

Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial

Molecular cancer therapeutics, 2007-03, Vol.6 (3), p.945-956

2007

Volltextzugriff (PDF)

Collaborative virtual screening to elaborate an imidazo[1,2-]pyridine hit series for visceral leishmaniasis

RSC medicinal chemistry, 2021-04, Vol.12 (3), p.384-393

2021

Volltextzugriff (PDF)

Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223

Journal of medicinal chemistry, 2015-07, Vol.58 (13), p.5323-5333

2015

Volltextzugriff (PDF)

Filarial nematode phenotypic screening cascade to identify compounds with anti-parasitic activity for drug discovery optimization

International journal for parasitology -- drugs and drug resistance, 2022-08, Vol.19, p.89-97

2022

Volltextzugriff (PDF)

Novel Poly(ADP-ribose) Polymerase-1 Inhibitor, AG14361, Restores Sensitivity to Temozolomide in Mismatch Repair-Deficient Cells

Clinical cancer research, 2004-02, Vol.10 (3), p.881-889

2004

Volltextzugriff (PDF)

Activation of specific RXR heterodimers by an antagonist of RXR homodimers

Nature (London), 1996-10, Vol.383 (6599), p.450-453

1996

Volltextzugriff (PDF)

Strategies Employed for the Development of PARP Inhibitors

Methods in molecular biology (Clifton, N.J.), 2017, Vol.1608, p.271

2017

Volltextzugriff (PDF)

Collaborative Virtual Screening Identifies a 2‑Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection

Journal of medicinal chemistry, 2023-01, Vol.66 (2), p.1221-1238

2023

Volltextzugriff (PDF)

Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial Infections

Journal of medicinal chemistry, 2022-08, Vol.65 (16), p.11388-11403

2022

Volltextzugriff (PDF)

Enantioselective preparation of .beta.-alkyl-.gamma.-butyrolactones from functionalized ketene dithioacetals

Journal of organic chemistry, 1993-05, Vol.58 (10), p.2725-2737

1993

Volltextzugriff (PDF)

Novel Tricyclic Poly(ADP-ribose) Polymerase-1 Inhibitors with Potent Anticancer Chemopotentiating Activity: Design, Synthesis, and X-ray Cocrystal Structure

Journal of medicinal chemistry, 2002-11, Vol.45 (23), p.4961-4974

2002

Volltextzugriff (PDF)

Identification of the First Retinoid X Receptor Homodimer Antagonist

Journal of medicinal chemistry, 1996-08, Vol.39 (17), p.3229-3234

1996

Volltextzugriff (PDF)

Discovery of a Stress-Activated Protein Kinase Inhibitor for Lymphatic Filariasis

ACS medicinal chemistry letters, 2018-03, Vol.9 (3), p.210-214

2018

Volltextzugriff (PDF)

Aza-retinoids as novel retinoid X receptor-specific agonists

Bioorganic & medicinal chemistry letters, 2006-05, Vol.16 (9), p.2352-2356

2006

Volltextzugriff (PDF)

Synthesis of Retinoid X Receptor-Specific Ligands That Are Potent Inducers of Adipogenesis in 3T3-L1 Cells

Journal of medicinal chemistry, 1999-02, Vol.42 (4), p.742-750

1999

Volltextzugriff (PDF)

Strategies employed for the development of PARP inhibitors

Methods in molecular biology (Clifton, N.J.), 2011, Vol.780, p.463

2011

Volltextzugriff (PDF)

Modified Conditions for Efficient Baeyer-Villiger Oxidation with m-CPBA

Synthetic communications, 1989-03, Vol.19 (5-6), p.829-833

1989

Volltextzugriff (PDF)

Stereochemistry of the terminating methyl .fwdarw. methylene elimination in kaurene biosynthesis

Journal of the American Chemical Society, 1986-05, Vol.108 (10), p.2762-2764

1986

Volltextzugriff (PDF)

Synthesis and structure-activity relationships of potent retinoid X receptor ligands

Bioorganic & medicinal chemistry letters, 1997-09, Vol.7 (18), p.2393-2398

1997

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(28)
Japanisch
(7)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Discovery of the c‑Jun N‑Terminal Kinase Inhibitor CC-90001

Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115

Systematic Study of Heteroarene Stacking Using a Congeneric Set of Molecular Glues for Procaspase‑6

The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen

CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization

Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB

Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial

Collaborative virtual screening to elaborate an imidazo[1,2-]pyridine hit series for visceral leishmaniasis

Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223

Filarial nematode phenotypic screening cascade to identify compounds with anti-parasitic activity for drug discovery optimization

Novel Poly(ADP-ribose) Polymerase-1 Inhibitor, AG14361, Restores Sensitivity to Temozolomide in Mismatch Repair-Deficient Cells

Activation of specific RXR heterodimers by an antagonist of RXR homodimers

Strategies Employed for the Development of PARP Inhibitors

Collaborative Virtual Screening Identifies a 2‑Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection

Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial Infections

Enantioselective preparation of .beta.-alkyl-.gamma.-butyrolactones from functionalized ketene dithioacetals

Novel Tricyclic Poly(ADP-ribose) Polymerase-1 Inhibitors with Potent Anticancer Chemopotentiating Activity: Design, Synthesis, and X-ray Cocrystal Structure

Identification of the First Retinoid X Receptor Homodimer Antagonist

Discovery of a Stress-Activated Protein Kinase Inhibitor for Lymphatic Filariasis

Aza-retinoids as novel retinoid X receptor-specific agonists

Synthesis of Retinoid X Receptor-Specific Ligands That Are Potent Inducers of Adipogenesis in 3T3-L1 Cells

Strategies employed for the development of PARP inhibitors

Modified Conditions for Efficient Baeyer-Villiger Oxidation with m-CPBA

Stereochemistry of the terminating methyl .fwdarw. methylene elimination in kaurene biosynthesis

Synthesis and structure-activity relationships of potent retinoid X receptor ligands

Suchergebnisse filtern